Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (33)
Marie-France Hivert, Frédérique White, Catherine Allard, Kaitlyn James, Sana Majid, François Aguet, Kristin G. Ardlie, Jose C. Florez, Andrea G. Edlow, Luigi Bouchard, Pierre-Étienne Jacques, S. Ananth Karumanchi & Camille E. Powe. (2024) Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes. Nature Medicine.
Crossref
Crossref
Min Cao & Bin Cui. (2024) Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses. Cardiovascular Diabetology 23:1.
Crossref
Crossref
Anne Linde Mak, Quinten J. J. Augustijn, Clément J. F. Heymann, Stefan Havik, Xanthe Verdoes, Melany Rios-Morales, Laura A. Bosmans, Joanne Verheij, Abraham S. Meijnikman, Patrick A. de Jonge, Hilde Herrema, Willem M. de Vos, Max Nieuwdorp, Aldo Grefhorst & Adriaan G. Holleboom. (2024) Anaerobutyricum soehngenii Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice. International Journal of Molecular Sciences 25:6, pages 3481.
Crossref
Crossref
Alper Yavas, Maaike van Putten & Annemieke Aartsma-Rus. (2024) Antisense Oligonucleotide-Mediated Downregulation of IGFBPs Enhances IGF-1 Signaling. Journal of Neuromuscular Diseases 11:2, pages 299-314.
Crossref
Crossref
Carolina Guzmán, Miriam G. Bautista-Ubaldo, Adriana Campos-Espinosa, Ivette I. Romero-Bello, Ángel Daniel Santana-Vargas & Gabriela Gutierrez-Reyes. (2024) Insulin-like Growth Factor Binding Proteins and Cellular Senescence Are Involved in the Progression of Non-Alcoholic Fatty Liver Disease and Fibrosis in a Mouse Model. Medicina 60:3, pages 429.
Crossref
Crossref
Tong-Hao Wang, Jian-Biao Li, Yong-Gang Tian, Jin-Xin Zheng, Xiao-Dong Li & Shu-zhang Guo. (2023) Association of TNF-α, IGF-1, and IGFBP-1 levels with the severity of osteopenia in mice with nonalcoholic fatty liver disease. Journal of Orthopaedic Surgery and Research 18:1.
Crossref
Crossref
Ruirui Gui, Wanqiao Li, Zhipeng Li, Hongbin Wang, Yuchen Wu, Wenlin Jiao, Gang Zhao, Yannan Shen, Luping Wang, Jialu Zhang, Sihan Chen, Linlin Hao & Yunyun Cheng. (2023) Effects and potential mechanisms of IGF1/IGF1R in the liver fibrosis: A review. International Journal of Biological Macromolecules 251, pages 126263.
Crossref
Crossref
Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Elena Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, Vasile Andrei Olteanu & Gabriela Ștefănescu. (2023) Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease. Metabolites 13:11, pages 1115.
Crossref
Crossref
Kaixuan Li, Ke Ding, Quan Zhu, Feng Han, Xi He, Shuo Tan, Ziqiang Wu, Zhihuan Zheng, Zhengyan Tang & Yanling Liu. (2023) Extracellular matrix stiffness aggravates urethral stricture through Igfbp3/Smad pathway. Scientific Reports 13:1.
Crossref
Crossref
Efstathia Thymiakou, Maria Tzardi & Dimitris Kardassis. (2023) Impaired hepatic glucose metabolism and liver-α-cell axis in mice with liver-specific ablation of the Hepatocyte Nuclear Factor 4α (Hnf4a) gene. Metabolism 139, pages 155371.
Crossref
Crossref
David Haldrup, Chunshan Wei, Peter Holland-Fischer, Kurt Kristensen, Søren Rittig, Aksel Lange, Arne Hørlyck, Jan Solvig, Henning Grønbæk, Niels H. Birkebæk & Jan Frystyk. (2022) Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease. European Journal of Pediatrics 182:2, pages 855-865.
Crossref
Crossref
Christoffer A. Hagemann, Christian Legart, Mathias B. Møllerhøj, Martin R. Madsen, Henrik H. Hansen, Merete J. Kønig, Frederik Helgstrand, Flemming P. Hjørne, Anders Toxværd, Jill L. Langhoff, Urd L. Kielgast, Lise L. Gluud, Helene Ægidius, Kristoffer T. G. Rigbolt, Tina Vilsbøll, Jacob Jelsing & Filip K. Knop. (2022) A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity. PLOS ONE 17:10, pages e0275901.
Crossref
Crossref
Xinzhi Li, Kaixin Ding, Xueying Li, Bingchuan Yuan, Yuqin Wang, Zhicheng Yao, Shuaikang Wang, He Huang, Bolin Xu, Liwei Xie, Tuo Deng, Xiao-wei Chen & Zheng Chen. (2022) Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH). Nature Communications 13:1.
Crossref
Crossref
Seda Turgut, Didem Acarer, Hakan Seyit, Naim Pamuk, Hamide Piskinpasa, Evin Bozkur, Mehmet Karabulut & Ilkay Cakir. (2022) Insulin-Like Growth Factor-I Might be a Predictor for Severe
Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients. Hormone and Metabolic Research.
Crossref
Crossref
Hemalatha Mani, Jui-Hung Yen, Hao-Jen Hsu, Chun-Chun Chang & Je-Wen Liou. (2022) Hepatitis C virus core protein: Not just a nucleocapsid building block, but an immunity and inflammation modulator. Tzu Chi Medical Journal 34:2, pages 139.
Crossref
Crossref
Robim M. Rodrigues, Yong He, Seonghwan Hwang, Adeline Bertola, Bryan Mackowiak, Yeni Ait Ahmed, Wonhyo Seo, Jing Ma, Xiaolin Wang, Seol Hee Park, Yukun Guan, Yaojie Fu, Tamara Vanhaecke, Dechun Feng & Bin Gao. (2022) E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9. Cellular and Molecular Gastroenterology and Hepatology 13:1, pages 151-171.
Crossref
Crossref
Jiaqi Pan, Li Cen, Tianyu Zhou, Mengli Yu, Xueyang Chen, Wenxi Jiang, Youming Li, Chaohui Yu & Zhe Shen. (2021) Insulin‐like growth factor binding protein 1 ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 36:12, pages 3438-3447.
Crossref
Crossref
Yi Luo, Samir Wadhawan, Alex Greenfield, Benjamin E. Decato, Abdul M. Oseini, Rebecca Collen, Diane E. Shevell, John Thompson, Gabor Jarai, Edgar D. Charles & Arun J. Sanyal. (2021) SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH. Hepatology Communications 5:5, pages 760-773.
Crossref
Crossref
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia & Elisabetta Bugianesi. (2021) Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. Metabolites 11:3, pages 155.
Crossref
Crossref
Pablo J. Giraudi, Michela Giuricin, Deborah Bonazza, Nicolò de Manzini, Claudio Tiribelli, Silvia Palmisano & Natalia Rosso. (2020) Modifications of IGF2 and EGFR plasma protein concentrations in NAFLD patients after bariatric surgery. International Journal of Obesity 45:2, pages 374-382.
Crossref
Crossref
D. Rosique-Oramas, M. Martínez-Castillo, A. Raya, Z. Medina-Ávila, F. Aragón, J. Limón-Castillo, A. Hernández-Barragán, A. Santoyo, E. Montalvo-Javé, J.L. Pérez-Hernández, F. Higuera-de la Tijera, A. Torre, D. Kershenobich & G. Gutiérrez-Reyes. (2020) Production of insulin-like growth factor-binding proteins during the development of hepatic fibrosis due to chronic hepatitis C. Revista de Gastroenterología de México (English Edition) 85:4, pages 390-398.
Crossref
Crossref
D. Rosique-Oramas, M. Martínez-Castillo, A. Raya, Z. Medina-Ávila, F. Aragón, J. Limón-Castillo, A. Hernández-Barragán, A. Santoyo, E. Montalvo-Javé, J.L. Pérez-Hernández, F. Higuera-de la Tijera, A. Torre, D. Kershenobich & G. Gutiérrez-Reyes. (2020) Producción de las proteínas de unión al factor de crecimiento insulinoide durante el desarrollo de la fibrosis hepática por hepatitis C crónica. Revista de Gastroenterología de México 85:4, pages 390-398.
Crossref
Crossref
Amanda M. Artsen, Rui Liang, Leslie Meyn, Matthew Rytel, Stacy Palcsey, Steven D. Abramowitch & Pamela A. Moalli. (2020) T regulatory cells and TGF-β1: Predictors of the host response in mesh complications. Acta Biomaterialia 115, pages 127-135.
Crossref
Crossref
Zheng Xiao, Yafei Chu & Wangsen Qin. (2020) IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease. Life Sciences 256, pages 117997.
Crossref
Crossref
Carley J. S. Heck, Herana Kamal Seneviratne & Namandjé N. Bumpus. (2020) Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death. Journal of Medicinal Chemistry 63:12, pages 6561-6574.
Crossref
Crossref
Naeimeh Atabaki-Pasdar, Mattias Ohlsson, Ana Viñuela, Francesca Frau, Hugo Pomares-Millan, Mark Haid, Angus G. Jones, E. Louise Thomas, Robert W. Koivula, Azra Kurbasic, Pascal M. Mutie, Hugo Fitipaldi, Juan Fernandez, Adem Y. Dawed, Giuseppe N. Giordano, Ian M. Forgie, Timothy J. McDonald, Femke Rutters, Henna Cederberg, Elizaveta Chabanova, Matilda Dale, Federico De Masi, Cecilia Engel Thomas, Kristine H. Allin, Tue H. Hansen, Alison Heggie, Mun-Gwan Hong, Petra J. M. Elders, Gwen Kennedy, Tarja Kokkola, Helle Krogh Pedersen, Anubha Mahajan, Donna McEvoy, Francois Pattou, Violeta Raverdy, Ragna S. Häussler, Sapna Sharma, Henrik S. Thomsen, Jagadish Vangipurapu, Henrik Vestergaard, Leen M. ‘t Hart, Jerzy Adamski, Petra B. Musholt, Soren Brage, Søren Brunak, Emmanouil Dermitzakis, Gary Frost, Torben Hansen, Markku Laakso, Oluf Pedersen, Martin Ridderstråle, Hartmut Ruetten, Andrew T. Hattersley, Mark Walker, Joline W. J. Beulens, Andrea Mari, Jochen M. Schwenk, Ramneek Gupta, Mark I. McCarthy, Ewan R. Pearson, Jimmy D. Bell, Imre Pavo & Paul W. Franks. (2020) Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts. PLOS Medicine 17:6, pages e1003149.
Crossref
Crossref
Moisés Martínez-Castillo, Dorothy Rosique-Oramas, Zaira Medina-Avila, José Luis Pérez-Hernández, Fatima Higuera-De la Tijera, Daniel Santana-Vargas, Eduardo Esteban Montalvo-Jave, Francico Sanchez-Avila, Aldo Torre, David Kershenobich & Gabriela Gutierrez-Reyes. (2020) Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression. Molecular and Cellular Biochemistry 469:1-2, pages 65-75.
Crossref
Crossref
Hannah Drescher, Sabine Weiskirchen & Ralf Weiskirchen. (2019) Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). Cells 8:8, pages 845.
Crossref
Crossref
Lauren Pavlik, Arie Regev, Paul A. Ardayfio & Naga P. Chalasani. (2019) Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Drug Safety 42:6, pages 701-711.
Crossref
Crossref
Dorothy Rosique-Oramas, Moises Martinez-Castillo, Carolina Guzman, José Luis Pérez Hernández, Jacqueline Cordova-Gallardo, Luis Very-Pineda, Fatima Higuera-De La Tijera, Daniel Santana-Vargas, Eduardo Montalvo-Jave, Francisco Sanchez-Avila, Paula Cordero Perez, Linda Muñoz-Espinosa, David Kershenobich & Gabriela Gutiérrez-Reyes. 2019. Liver Cirrhosis - Debates and Current Challenges. Liver Cirrhosis - Debates and Current Challenges.
Hirokazu Takahashi, Kazuhiko Kotani, Kenichi Tanaka, Yuichiro Egucih & Keizo Anzai. (2018) Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms. Frontiers in Endocrinology 9.
Crossref
Crossref
Mekonnen L. Dechassa, Volodymyr Tryndyak, Aline de Conti, Wenming Xiao, Frederick A. Beland & Igor P. Pogribny. (2018) Identification of chromatin‐accessible domains in non‐alcoholic steatohepatitis‐derived hepatocellular carcinoma. Molecular Carcinogenesis 57:8, pages 978-987.
Crossref
Crossref
Agnieszka Adamek & Aldona Kasprzak. (2018) Insulin-Like Growth Factor (IGF) System in Liver Diseases. International Journal of Molecular Sciences 19:5, pages 1308.
Crossref
Crossref